- Global Pharma News & Resources

TraceLink Achieves 59% Overall Revenue Growth for Q4 2018

NORTH READING, Mass., Feb. 26, 2019 /PRNewswire/ -- TraceLink Inc., the world's largest integrated digital supply network, providing real-time information sharing for better patient outcomes, today announced financial and company results for the fourth quarter of 2018.

Financial growth highlights for Q4 2018 include:

  • A 59 percent year-over-year increase in annual revenue, including growth in the following regions:
    • 172 percent revenue growth in EMEA;
    • 193 percent revenue growth in APAC; and,
    • 80 percent revenue growth in India.

  • A two-year revenue compound annual growth rate (CAGR) of 71 percent;

  • A total of 1,099 customers by the end of Q4, representing a 42 percent year-over-year increase in total customers, located across 45 countries, including:
    • 64 percent representing pharmaceutical and contract manufacturers;
    • 5 percent representing wholesale distributors, 3PLs and repackagers; and,
    • 31 percent representing pharmacies, hospitals, clinics and health systems.

  • A total of 506 employees worldwide at the end of Q4.

"Through TraceLink's integrated digital supply network, we have helped thousands of customers and partners successfully prepare for serialization requirements, while positioning them with a platform of additional solutions to digitalize their supply chains," said Shabbir Dahod, president and CEO, TraceLink. "Companies on the TraceLink network have commissioned over 1.4 billion serial numbers, generating a massive amount of data that has fueled our unique capability to develop new and innovative digital solutions that maximize the efficacy, safety, security and availability of products to improve human life."

Additional Q4 2018 growth highlights and milestones include:

  • Leading the market with the industry's most serialization-ready customers – with 470 companies on the TraceLink network that are live with serialization.
  • Demonstrating unmatched scalability with a total of 1.4 billion serial numbers commissioned by TraceLink customers – and 476 million regulatory compliance documents processed.
  • Accelerating company and trade partner connectivity with a true "network effect"– with more than 1,000 unique connections to CMOs on the TraceLink network.
  • Helping more than 350 companies meet the EU FMD February 2019 deadline – with 192 EU Hub production connections that have EMVO approval.
  • Hosting FutureLink, the industry's only thought leadership forum for the end-to-end supply chain – with 35 presentations and  170 attendees at FutureLink Chicago; and announcing FutureLink Barcelona to take place June 11-13, 2019.
  • Announcing a saleable returns verification solution for both pharmaceutical manufacturers and wholesale distributors – an end-to-end solution for processing saleable returns to meet the November 2019 DSCSA requirement, including a verification router service (VRS) and master data sharing capabilities built on TraceLink's Product Information Manager network application with edge functionality.
  • Bringing the industry together through the TraceLink Customer Community – surpassing 4,000 members, with 133 new members joining in Q4, and hosting over 40 virtual and in person meetings, the Community provides a platform for networking, innovation and education that is shaping the future of an integrated digital supply network. 

Additional Resources:

Follow TraceLink:

About TraceLink
TraceLink is the world's largest integrated digital supply network, providing real-time information sharing for better patient outcomes. Leading businesses trust the TraceLink Life Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. The TraceLink digital supply network is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit

TraceLink is funded by Georgian Partners, Willett Advisors LLC, Vulcan Capital, Goldman Sachs, FirstMark Capital, Volition Capital and F-Prime Capital.

View original content to download multimedia:

SOURCE TraceLink Inc.

Editor Details

Last Updated: 26-Feb-2019